The Killer 50
-
Optibrium expands to new Cambridge HQ
Optibrium™, a developer of software for drug discovery, has expanded its UK headquarters with a move to larger office premises on Cambridge... Read More
-
ieso study proves value of integrated approaches for mental healthcare in diabetes
ieso, Cambridge’s data-driven AI healthcare company pioneering next-generation digital therapeutics in mental health, has unveiled study results... Read More
-
Darktrace CEO calls for ‘tech NATO’ to police cybercrime
The CEO of Killer50 superstar Darktrace says there is “a shocking tolerance” to cyber attacks and urges additional vigilance. Poppy Gustafsson... Read More
-
CMR Surgical opens Brazil office with Chile next in Latin America push
Surgery with a samba backbeat marks the latest exciting exploit for CMR Surgical in Cambridge. The pioneering MedTech company is planning major... Read More
-
1Spatial wins maiden New York deal
Cambridge-based location technology specialist 1Spatial has taken a first bite out of the Big Apple via a maiden contract with the State of New York... Read More
-
Alchemab identifies cancer and neurodegenerative disease drug targets
Cambridge-based biotech company Alchemab Therapeutics is enjoying widespread success with its trailblazing transformer neural network, AntiBERTa.... Read More
-
Evonetix granted European patent for novel gene assembly method
Cambridge synthetic biology company Evonetix has strengthened its IP portfolio by earning a European patent covering its Binary Assembly method for... Read More
-
STORM Therapeutics funded to fight coronavirus diseases
Cambridge University spin-out STORM Therapeutics has won an unspecified Biomedical Catalyst grant by Innovate UK to research and develop new drugs... Read More
-
French connection helps Cambridge Mechatronics in nextgen haptics play
Cambridge Mechatronics (CML), and French company Interhaptics have agreed a strategic collaboration to bring a cutting-edge AR/VR haptics technology... Read More
-
Evonetix DNA IP boosted by European patent
Evonetix, a Cambridge-based synthetic biology company, has won a significant patent approval in Europe. It covers the company’s proprietary thermal... Read More
-
GW parent company creates 100 jobs with new facility
The marriage of Cambridge biotechnology with Irish nous and cash – allied to US visibility – are all evidenced in a major UK expansion for Nasdaq-... Read More
-
Arecor wins key US patent milestone for diabetes products
Cambridge’s Arecor Therapeutics plc has won a key patent approval in the US as it turns its IP portfolio into a veritable pharma fortress. The... Read More
-
Alchemab and Medicines Discovery Catapult pioneer fresh advances
Cambridge biotech Alchemab Therapeutics has extended a collaboration with Medicines Discovery Catapult (MDC) – a national facility enabling the UK’s... Read More
-
Adrestia Therapeutics
Adrestia Therapeutics secured undisclosed Series A investment from GSK in 2020 to progress technology designed to restore diseased cells by... Read More
-
Tenyks
Tenyks, a University of Cambridge spin-out focused on helping machine learning engineers build better, safer AI, raised a $3.4 million seed round in... Read More
-
Treatt plc
Treatt is a trusted natural extracts and ingredients manufacturer and supplier to the global beverage, flavour, fragrance and consumer goods markets... Read More
-
Quantinuum
The world’s largest integrated quantum computing company – Quantinuum – was recently rolled out by Honeywell Quantum Solutions and Cambridge Quantum... Read More
-
Qureight
Qureight is a Cambridge company which uses cloud-based technology to assist in the structuring of image and paired clinical metadata in complex... Read More
-
Porotech
Porotech is a spin-out from the Cambridge Centre for Gallium Nitride in the Department of Materials Science and Metallurgy at the University of... Read More
-
Nu Quantum
Nu Quantum is creating high-performance, single-photon technologies that will predicate the future of quantum information processing. The scalable... Read More